Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$603.79 USD

603.79
924,883

+6.87 (1.15%)

Updated Oct 14, 2024 04:00 PM ET

After-Market: $603.80 +0.01 (0.00%) 7:48 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (96 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Hologic (HOLX) Receives EUA for Asymptomatic Coronavirus Testing

The FDA approves Hologic's (HOLX) Panther Fusion SARS-CoV-2 assay and pooling protocol to curb the unrelenting spread of coronavirus.

Medtronic, Axonics Patent War Continues for Sacral Neuromodulation (Revised)

Medtronic's (MDT) InterStim system electrically stimulates the sacral nerves.

Urmimala Biswas headshot

3 Picks to Ride the Coronavirus-Led Strength in Lab Plastic Space

These laboratory equipment suppliers' fate does not depend on the end result of the R&D outcomes of the drug and vaccine makers.

Veeva Collaborates With RedHill for Coronavirus Clinical Study

RedHill has adopted Veeva's (VEEV) Vault CDMS platform for the opaganib study.

Here's Why You Should Retain Change Healthcare (CHNG) Stock

Change Healthcare (CHNG) continues to benefit from robust payment accuracy business and strategic deals. However, intense competition remains a woe.

Surmodics' Pounce Thrombus Retrieval System Gets FDA Nod

The FDA clearance of Surmodics' (SRDX) Pounce Thrombus Retrieval System will bolster the current treatment of complex PAD.

The Zacks Analyst Blog Highlights: Procter & Gamble, Verizon, Thermo Fisher Scientific, Nvidia and Nike

The Zacks Analyst Blog Highlights: Procter & Gamble, Verizon, Thermo Fisher Scientific, Nvidia and Nike

Thermo Fisher Scientific (TMO) Gains But Lags Market: What You Should Know

Thermo Fisher Scientific (TMO) closed the most recent trading day at $428.39, moving +1.44% from the previous trading session.

Syneos Health Banks on Essential Therapies Amid Coronavirus Woe

Syneos Health's (SYNH) over 70% of clinical businesses comprise essential therapeutic areas that are experiencing reduced impacts of coronavirus outbreak.

Medtronic Wins Neuromodulation Patent Dispute Against Axonics

Medtronic's (MDT) InterStim system electrically stimulates the sacral nerves.

Here's Why You Should Hold on to Hill-Rom (HRC) Stock for Now

Investors continue to be optimistic about Hill-Rom (HRC) on product launches as well as solid third-quarter of fiscal 2020 results.

Quest Diagnostics Partners in Pilot Program for COVID-19 Test

Quest Diagnostics (DGX) to provide online test results for COVID-19 samples collected via drone-delivered at-home self-collection kits as part of a pilot program.

Here's Why You Should Avoid Betting on Integer Holdings Now

Stiff competition in the MedTech space and weak segmental and operational performance weighs on Integer Holdings (ITGR).

Cerner Inks Deal to Simplify Advance Care Planning Procedure

Cerner's (CERN) partners with Vynca to simplify advance care planning process, thereby enabling patients and clinicians to discuss and make critical end-of-life decisions.

Sheraz Mian headshot

Top Analyst Reports for P&G, Verizon & Thermo Fisher

Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), Verizon Communications (VZ) and Thermo Fisher Scientific (TMO).

Is Thermo Fisher Scientific (TMO) Outperforming Other Medical Stocks This Year?

Is (TMO) Outperforming Other Medical Stocks This Year?

NuVasive Banks on Product Launches Amid Procedural Volume Loss

NuVasive (NUVA) is leaving no stone unturned to capture the fast-growing spine market.

Boston Scientific, Farapulse Sign Deal for Treatment of AF

Boston Scientific (BSX) aims to provide a comprehensive portfolio of electrophysiology products and services via the latest investment agreement.

Abbott's MitraClip G4 Receives CE Mark for Treatment of MR

Abbott's (ABT) MitraClip G4 is expected to improve MR patients' quality of life post its usage eligibility in Europe and other countries recognizing the CE Mark.

LabCorp Boosts Oncology Offerings With Resolution ctDx Launch

This development comes on the heels of LabCorp's (LH) commercial partnership with non-invasive liquid biopsy platform developer, Resolution Bioscience.

Baxter's Clinimix and Clinimix E Injections Receive FDA Nod

Baxter's (BAX) Clinimix and Clinimix E with Higher Protein Injection received FDA approval, which will help clinicians to improve care for critically ill patients.

Quest Diagnostics New Tests Uptake Strong Amid Coronavirus Woe

Heavy demand for COVID-19 molecular testing helps partially offset the base volume decline for Quest Diagnostics (DGX).

Medtronic TYRX Driveline Gets FDA's Breakthrough Designation

This development helps Medtronic (MDT) to augment its research work in the space of interventional and surgical treatment of cardiovascular disease and cardiac arrhythmias.

Here's Why You Should Hold on to ResMed (RMD) Stock for Now

Investors continue to be positive about ResMed (RMD) owing to its robust product line and consistent high demand for its critical care products.

Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know

Thermo Fisher Scientific (TMO) closed the most recent trading day at $430.24, moving +1.12% from the previous trading session.